Cargando…

Critical Illness Neuromyopathy Complicating Akinetic Crisis in Parkinsonism: Report of 3 Cases

Akinetic crisis (AC) is a life-threatening complication of parkinsonism characterized by an acute severe akinetic-hypertonic state, consciousness disturbance, hyperthermia, and muscle enzymes elevation. Injectable dopaminomimetic drugs, high-dose methylprednisolone, and dantrolene are advocated as p...

Descripción completa

Detalles Bibliográficos
Autores principales: Capasso, Margherita, De Angelis, Maria Vittoria, Di Muzio, Antonio, Anzellotti, Francesca, Bonanni, Laura, Thomas, Astrid, Onofrj, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617089/
https://www.ncbi.nlm.nih.gov/pubmed/26181547
http://dx.doi.org/10.1097/MD.0000000000001118
_version_ 1782396762544144384
author Capasso, Margherita
De Angelis, Maria Vittoria
Di Muzio, Antonio
Anzellotti, Francesca
Bonanni, Laura
Thomas, Astrid
Onofrj, Marco
author_facet Capasso, Margherita
De Angelis, Maria Vittoria
Di Muzio, Antonio
Anzellotti, Francesca
Bonanni, Laura
Thomas, Astrid
Onofrj, Marco
author_sort Capasso, Margherita
collection PubMed
description Akinetic crisis (AC) is a life-threatening complication of parkinsonism characterized by an acute severe akinetic-hypertonic state, consciousness disturbance, hyperthermia, and muscle enzymes elevation. Injectable dopaminomimetic drugs, high-dose methylprednisolone, and dantrolene are advocated as putative specific treatments. The course of the illness is frequently complicated by infections, pulmonary embolism, renal failure, disseminated intravascular coagulation, and cardiac arrhythmias. Critical illness neuromyopathy (CINM) is an acquired neuromuscular disorder characterized by flaccid quadriparesis and muscle enzyme elevation, often occurring in intensive care units and primarily associated with inactivity, sepsis, multiorgan failure, neuromuscular blocking agents, and steroid treatment. In 3 parkinsonian patients, during the course of AC we observed disappearance of rigidity but persistent hypoactivity. In all, neurological examination showed quadriparesis with loss of tendon reflexes and laboratory investigation disclosed a second peak of muscle enzymes elevation, following the first increment due to AC. Electrophysiological studies showed absent or reduced sensory nerve action potentials and compound muscular action potentials, myopathic changes, and fibrillation potentials at electromyography recordings, and reduced excitability or inexcitability of tibialis anterior at direct muscle stimulation, leading to a diagnosis of CINM in all 3 patients. In 1 patient, the diagnosis was also confirmed by muscle biopsy. Outcome was fatal in 2 of the 3 patients. Although AC is associated with most of the known risk factors for CINM, the cooccurrence of the 2 disorders may be difficult to recognize and has never been reported. We found that CINM can occur as a severe complication of AC, and should be suspected when hypertonia-rigidity subsides despite persistent akinesia. Strict monitoring of muscle enzyme levels may help diagnosis. This finding addresses possible caveats in the use of putative treatments for AC.
format Online
Article
Text
id pubmed-4617089
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-46170892015-10-27 Critical Illness Neuromyopathy Complicating Akinetic Crisis in Parkinsonism: Report of 3 Cases Capasso, Margherita De Angelis, Maria Vittoria Di Muzio, Antonio Anzellotti, Francesca Bonanni, Laura Thomas, Astrid Onofrj, Marco Medicine (Baltimore) 5300 Akinetic crisis (AC) is a life-threatening complication of parkinsonism characterized by an acute severe akinetic-hypertonic state, consciousness disturbance, hyperthermia, and muscle enzymes elevation. Injectable dopaminomimetic drugs, high-dose methylprednisolone, and dantrolene are advocated as putative specific treatments. The course of the illness is frequently complicated by infections, pulmonary embolism, renal failure, disseminated intravascular coagulation, and cardiac arrhythmias. Critical illness neuromyopathy (CINM) is an acquired neuromuscular disorder characterized by flaccid quadriparesis and muscle enzyme elevation, often occurring in intensive care units and primarily associated with inactivity, sepsis, multiorgan failure, neuromuscular blocking agents, and steroid treatment. In 3 parkinsonian patients, during the course of AC we observed disappearance of rigidity but persistent hypoactivity. In all, neurological examination showed quadriparesis with loss of tendon reflexes and laboratory investigation disclosed a second peak of muscle enzymes elevation, following the first increment due to AC. Electrophysiological studies showed absent or reduced sensory nerve action potentials and compound muscular action potentials, myopathic changes, and fibrillation potentials at electromyography recordings, and reduced excitability or inexcitability of tibialis anterior at direct muscle stimulation, leading to a diagnosis of CINM in all 3 patients. In 1 patient, the diagnosis was also confirmed by muscle biopsy. Outcome was fatal in 2 of the 3 patients. Although AC is associated with most of the known risk factors for CINM, the cooccurrence of the 2 disorders may be difficult to recognize and has never been reported. We found that CINM can occur as a severe complication of AC, and should be suspected when hypertonia-rigidity subsides despite persistent akinesia. Strict monitoring of muscle enzyme levels may help diagnosis. This finding addresses possible caveats in the use of putative treatments for AC. Wolters Kluwer Health 2015-07-17 /pmc/articles/PMC4617089/ /pubmed/26181547 http://dx.doi.org/10.1097/MD.0000000000001118 Text en Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 5300
Capasso, Margherita
De Angelis, Maria Vittoria
Di Muzio, Antonio
Anzellotti, Francesca
Bonanni, Laura
Thomas, Astrid
Onofrj, Marco
Critical Illness Neuromyopathy Complicating Akinetic Crisis in Parkinsonism: Report of 3 Cases
title Critical Illness Neuromyopathy Complicating Akinetic Crisis in Parkinsonism: Report of 3 Cases
title_full Critical Illness Neuromyopathy Complicating Akinetic Crisis in Parkinsonism: Report of 3 Cases
title_fullStr Critical Illness Neuromyopathy Complicating Akinetic Crisis in Parkinsonism: Report of 3 Cases
title_full_unstemmed Critical Illness Neuromyopathy Complicating Akinetic Crisis in Parkinsonism: Report of 3 Cases
title_short Critical Illness Neuromyopathy Complicating Akinetic Crisis in Parkinsonism: Report of 3 Cases
title_sort critical illness neuromyopathy complicating akinetic crisis in parkinsonism: report of 3 cases
topic 5300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617089/
https://www.ncbi.nlm.nih.gov/pubmed/26181547
http://dx.doi.org/10.1097/MD.0000000000001118
work_keys_str_mv AT capassomargherita criticalillnessneuromyopathycomplicatingakineticcrisisinparkinsonismreportof3cases
AT deangelismariavittoria criticalillnessneuromyopathycomplicatingakineticcrisisinparkinsonismreportof3cases
AT dimuzioantonio criticalillnessneuromyopathycomplicatingakineticcrisisinparkinsonismreportof3cases
AT anzellottifrancesca criticalillnessneuromyopathycomplicatingakineticcrisisinparkinsonismreportof3cases
AT bonannilaura criticalillnessneuromyopathycomplicatingakineticcrisisinparkinsonismreportof3cases
AT thomasastrid criticalillnessneuromyopathycomplicatingakineticcrisisinparkinsonismreportof3cases
AT onofrjmarco criticalillnessneuromyopathycomplicatingakineticcrisisinparkinsonismreportof3cases